ORAL FORMULATIONS OF A BIOLOGICALLY ACTIVE PEPTIDE AND USES THEREOF Application EP-3920951-A4 European Patent Office 05 Jul 2023
Oral formulations of kappa opioid receptor agonists Grant US-11684674-B2 United States of America 27 Jun 2023
PREVENTION AND TREATMENT OF CORONAVIRUS-ASSOCIATED DISEASES USING AN APELIN PEPTIDE AND… Application WO-2021195580-A1 World Intellectual Property Organisation (WIPO) 30 Sep 2021
AEROSOLIZED FORMULATIONS OF AN APELIN PEPTIDE AND USES THEREOF Application WO-2021195581-A1 World Intellectual Property Organisation (WIPO) 30 Sep 2021